Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.2 USD | +0.19% | +12.40% | +34.98% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |